DSM becomes an investor and strategic partner
DSM Venturing, the corporate venturing unit of Royal DSM N.V., has become a minority shareholder in Bioprocess Control. In addition, a strategic cooperation agreement has been signed between DSM and Bioprocess Control to further explore and leverage the complementary technologies held by each company. DSM is a global leader in the material and life science industries and is headquartered in the Netherlands. The company has over 23,500 people worldwide, net sales of 9.3 billion Euros and is listed on the Euronext Amsterdam.